When we raised the SISH cut-off for amplification (≥3), the concordance was 100%, demonstrating that SISH is a valid testing method for HER2 testing in GC patients and that a higher cut-off (≥3) should be considered even for dual-colour SISH, in order to increase the concordance rate. Here, ERBB2 is linked to gastric cancer.